Vaccine hesitancy: drivers and how the allergy community can help
File(s)Vaccine hesitancy JACI_IP 2021 FINAL.pdf (352.24 KB)
Accepted version
Author(s)
Turner, Paul
Larson, Heidi
Dube, Eve
Fisher, Allison
Type
Journal Article
Abstract
Vaccine hesitancy—defined by the World Health Organization (WHO) as a “delay in acceptance or refusal of vaccines despite availability of vaccination services”—is not a recent phenomenon. Historical records indicate that vaccine hesitancy existed by the 18th century in Europe and even resulted in violent riots. The drivers of vaccine hesitancy have evolved over the last 200 years but not, perhaps, as much as one might expect. More problematic are the means by which concerns over vaccine hesitancy are communicated by a new landscape of digital communication, generating what has been described as an “infodemic” in which an overabundance of information—both factual and misinformation—contributes to hesitancy. In this review, we discuss the background and current drivers of vaccine hesitancy and the evidence base for strategies to combat this. We highlight the important role the allergy/immunology community could have in working to mitigate vaccine hesitancy, particularly with respect to the current coronavirus disease 2019 (COVID-19) pandemic.
Date Issued
2021-10-01
Date Acceptance
2021-06-19
Citation
Journal of Allergy and Clinical Immunology: In Practice, 2021, 9 (10), pp.3568-3574
ISSN
2213-2198
Publisher
Elsevier
Start Page
3568
End Page
3574
Journal / Book Title
Journal of Allergy and Clinical Immunology: In Practice
Volume
9
Issue
10
Copyright Statement
© 2021 Elsevier Ltd. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/
Identifier
https://www.sciencedirect.com/science/article/pii/S2213219821007637?via%3Dihub
Subjects
Anaphylaxis
COVID-19
Vaccination
Vaccine hesitancy
Vaccine refusal
COVID-19
Humans
Hypersensitivity
SARS-CoV-2
Vaccination
Vaccines
Humans
Hypersensitivity
Vaccines
Vaccination
COVID-19
SARS-CoV-2
Publication Status
Published
Date Publish Online
2021-07-06